Earnings History Data for Hemispherx BioPharma, Inc. (AIM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Hemispherx BioPharma, Inc.

AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
18-05-2021 PM AIM Hemispherx BioPharma, Inc. 79.78 -0.08 0.00 -0.22 AIM ImmunoTech EPS in-line, misses on revenue
[5/18/2021 7:41 AM]
2.08 0.0 
(0.00%)
2.04 -0.04 
(-1.92%)
1.60 - 4.30 264,971 800,000 7,771
31-03-2021 PM AIM Hemispherx BioPharma, Inc. 84.94 -0.09 0.00 0.00 AIM ImmunoTech EPS misses by $0.02, misses on revenue
[3/31/2021 10:39 AM]
0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0